Stifel Financial’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
Other funds holding TCRT
MP
MVP
DCM
Stifel Financial's TCRT Position: Q4 2020 in Review
Stifel Financial sold out of Alaunos Therapeutics (TCRT) in Q4 2020, closing a stake of 153 shares — an estimated $57K sold.
Stifel Financial first reported a position in TCRT in Q4 2014 and held it in 24 quarters. The position peaked at $749K in Q2 2015. 156 funds tracked by Wall St. Rank hold TCRT as of Q4 2020.
- Stifel Financial reported no remaining Alaunos Therapeutics position as of Q4 2020 after selling out during the quarter.
- Stifel Financial sold 153 Alaunos Therapeutics shares in Q4 2020, an estimated $57K.
- Stifel Financial first reported a position in Alaunos Therapeutics in Q4 2014 and held it in 24 quarters.
- Stifel Financial's Alaunos Therapeutics position peaked at $749K in Q2 2015.
- 156 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q4 2020.
Based on Stifel Financial's 13F filing for Q4 2020, filed 12 Feb 2021.